Protalix BioTherapeutics, Inc. (DE) (PLX): Price and Financial Metrics

PLX POWR Grades

• PLX scores best on the Value dimension, with a Value rank ahead of 81.83% of US stocks.
• PLX's strongest trending metric is Sentiment; it's been moving up over the last 161 days.
• PLX ranks lowest in Momentum; there it ranks in the 9th percentile.

PLX Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for PLX is 231.44 -- better than 99.83% of US stocks.
• With a one year PEG ratio of 0.35, Protalix BioTherapeutics Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than just 2.41% of US stocks.
• PLX's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 0.5% of US stocks.
• If you're looking for stocks that are quantitatively similar to Protalix BioTherapeutics Inc, a group of peers worth examining would be PTCT, POLY, STX, PRO, and AGEN.
• Visit PLX's SEC page to see the company's official filings. To visit the company's web site, go to www.protalix.com.

PLX Valuation Summary

• In comparison to the median Healthcare stock, PLX's price/sales ratio is 85.9% lower, now standing at 1.6.
• Over the past 243 months, PLX's price/sales ratio has gone NA NA.
• Over the past 243 months, PLX's EV/EBIT ratio has gone down 7.8.

Below are key valuation metrics over time for PLX.

PLX Growth Metrics

The 5 year price growth rate now stands at -57.47%.
• Its year over year cash and equivalents growth rate is now at 39.98%.
• Its 5 year net cashflow from operations growth rate is now at 30.15%.

PLX's revenue has moved up $15,056,000 over the prior 33 months.

The table below shows PLX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-09-30	49.296	-12.748	-20.518
2021-06-30	48.032	-14.472	-20.756
2021-03-31	52.572	-28.823	-13.665
2020-12-31	62.898	-26.106	-6.523
2020-09-30	61.162	-22.243	-6.629
2020-06-30	64.62	-21.864	-5.752

PLX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• PLX has a Quality Grade of C, ranking ahead of 73.31% of graded US stocks.
• PLX's asset turnover comes in at 0.547 -- ranking 71st of 681 Pharmaceutical Products stocks.
• MNKD, XTNT, and NBIX are the stocks whose asset turnover ratios are most correlated with PLX.

The table below shows PLX's key quality metrics over time.